UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Inhibitors in Hemophilia B

Seminars in thrombosis and hemostasis, 2018-09, Vol.44 (6), p.578

2018

Link zum Volltext

Verfügbarkeit prüfen

Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives

Annals of hematology, 2022-05, Vol.101 (5), p.963-978

2022

Link zum Volltext

Verfügbarkeit prüfen

Acquired Haemophilia A: An Intriguing Disease

Mediterranean journal of hematology and infectious diseases, 2020-07, Vol.12 (1), p.e2020045-e2020045

2020

Link zum Volltext

Verfügbarkeit prüfen

Secondary Prophylaxis of Venous Thromboembolism (VTE) with Low Dose Apixaban or Rivaroxaban: Results from a Patient Population with More than 2 Years of Median Follow-up

Mediterranean journal of hematology and infectious diseases, 2024, Vol.16 (1), p.e2024020-e2024020

2024

Link zum Volltext

Verfügbarkeit prüfen

Safety of Switching Factor VIII Products in the Era of Evolving Concentrates: Myths and Facts

Seminars in thrombosis and hemostasis, 2016-07, Vol.42 (5), p.563

2016

Link zum Volltext

Verfügbarkeit prüfen

Immune thrombocytopenia management during COVID‐19 pandemic: An Italian monocentric experience

EJHaem, 2022-05, Vol.3 (2), p.453-456

2022

Link zum Volltext

Verfügbarkeit prüfen

Severe Immune Thrombocytopenia (ITP) Following SARS-CoV-2 mRNA Vaccine in a Girl on Immunosuppressive Treatment and in Prolonged Stable Phase of ITP

Mediterranean journal of hematology and infectious diseases, 2022, Vol.14 (1), p.e2022011-e2022011

2022

Link zum Volltext

Verfügbarkeit prüfen

Severe Thrombotic Complications in Congenital Afibrinogenemia: A Pathophysiological and Management Dilemma

Seminars in thrombosis and hemostasis, 2016-07, Vol.42 (5), p.577

2016

Link zum Volltext

Verfügbarkeit prüfen

Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations

Therapeutic advances in hematology, 2021, Vol.12, p.20406207211048361-20406207211048361

2021

Link zum Volltext

Verfügbarkeit prüfen

Direct Oral Anticoagulants in Patients Affected by Major Congenital Thrombophilia

Mediterranean journal of hematology and infectious diseases, 2019, Vol.11 (1), p.e2019044-e2019044

2019

Link zum Volltext

Verfügbarkeit prüfen

Dental invasive procedures in von Willebrand disease outpatients treated with high purity FVIII/VWF complex concentrate (Fanhdi®): experience of a single center

Heliyon, 2020-02, Vol.6 (2), p.e03426-e03426, Article e03426

2020

Link zum Volltext

Verfügbarkeit prüfen

Hereditary protein C deficiency and thrombosis risk: genotype and phenotype relation in a large Italian family

European journal of haematology, 2012-04, Vol.88 (4), p.336-339

2012

Link zum Volltext

Verfügbarkeit prüfen

Tapentadol PR for Pain Syndromes in Real Life Patients with Hematological Malignancy

Cardiovascular & hematological agents in medicinal chemistry, 2016-04, Vol.14 (1), p.68

2016

Link zum Volltext

Verfügbarkeit prüfen

Right elbow arthropathy in a patient with severe haemophilia A

British journal of haematology, 2020-08, Vol.190 (4), p.484-484

2020

Link zum Volltext

Verfügbarkeit prüfen

Life-Threatening Autoimmune Hemolytic Anemia and Idhiopatic Thrombocytopenic Purpura. Successful Selective Splenic Artery Embolization

Mediterranean journal of hematology and infectious diseases, 2016, Vol.8 (1), p.e2016020

2016

Link zum Volltext

Verfügbarkeit prüfen

Fostamatinib combined with TPO‐RAs or steroids as a bridge to monotherapy or as time‐limited continuous treatment in relapsed chronic ITP: A single‐centre case series

British journal of haematology, 2024-05, Vol.204 (5), p.2129-2132

2024

Link zum Volltext

Verfügbarkeit prüfen

Life-threatening autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura: successful seletive splenic artery embolization

Mediterranean journal of hematology and infectious diseases, 2016-04, Vol.8, p.2016020-e2016020

2016

Link zum Volltext

Verfügbarkeit prüfen

Direct oral anticoagulants for the treatment of Mondor’s disease not responding to low-molecular weight heparin

Phlebology, 2020-10, Vol.35 (9), p.734-735

2020

Link zum Volltext

Verfügbarkeit prüfen

Satisfaction, quality of life and therapy adherence assessment in real life patients transitioning from vitamin K antagonists to direct oral anticoagulants

Journal of thrombosis and thrombolysis, 2020-10, Vol.50 (3), p.718-723

2020

Link zum Volltext

Verfügbarkeit prüfen

ACQUIRED HAEMOPHILIA A: AN INTRIGUING DISEASE: ACQUIRED HAEMOPHILIA A

Mediterranean journal of hematology and infectious diseases, 2020-06, Vol.12 (1), p.e2020045

2020

Link zum Volltext

Verfügbarkeit prüfen

Severe immune thrombocytopenia (ITP) following SARS-CoV-2 mRNA vaccine in a girl on immunosuppressive treatment and in prolonged stable phase of ITP: immune thrombocytopenia following mRNA vaccine

Mediterranean journal of hematology and infectious diseases, 2022-01, Vol.14 (1), p.e2022011

2022

Link zum Volltext

Verfügbarkeit prüfen

Single centre experience on Acquired Haemophilia A patients: Diagnosis, clinical management and analysis of factors predictive of response and outcome

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-11, Vol.27 (6), p.e667-e674

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(61)
Berichte
(4)

Sprache

Englisch
(65)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Inhibitors in Hemophilia B

Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives

Acquired Haemophilia A: An Intriguing Disease

Secondary Prophylaxis of Venous Thromboembolism (VTE) with Low Dose Apixaban or Rivaroxaban: Results from a Patient Population with More than 2 Years of Median Follow-up

Safety of Switching Factor VIII Products in the Era of Evolving Concentrates: Myths and Facts

Immune thrombocytopenia management during COVID‐19 pandemic: An Italian monocentric experience

Severe Immune Thrombocytopenia (ITP) Following SARS-CoV-2 mRNA Vaccine in a Girl on Immunosuppressive Treatment and in Prolonged Stable Phase of ITP

Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers

Severe Thrombotic Complications in Congenital Afibrinogenemia: A Pathophysiological and Management Dilemma

Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations

Direct Oral Anticoagulants in Patients Affected by Major Congenital Thrombophilia

Dental invasive procedures in von Willebrand disease outpatients treated with high purity FVIII/VWF complex concentrate (Fanhdi®): experience of a single center

PB2611: EVANS SYNDROME: DISEASE AWARENESS AND CLINICAL MANAGEMENT IN A NATION‐WIDE ITALIAN SURVEY

Hereditary protein C deficiency and thrombosis risk: genotype and phenotype relation in a large Italian family

Tapentadol PR for Pain Syndromes in Real Life Patients with Hematological Malignancy

Right elbow arthropathy in a patient with severe haemophilia A

Life-Threatening Autoimmune Hemolytic Anemia and Idhiopatic Thrombocytopenic Purpura. Successful Selective Splenic Artery Embolization

Fostamatinib combined with TPO‐RAs or steroids as a bridge to monotherapy or as time‐limited continuous treatment in relapsed chronic ITP: A single‐centre case series

Life-threatening autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura: successful seletive splenic artery embolization

Direct oral anticoagulants for the treatment of Mondor’s disease not responding to low-molecular weight heparin

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia

Satisfaction, quality of life and therapy adherence assessment in real life patients transitioning from vitamin K antagonists to direct oral anticoagulants

ACQUIRED HAEMOPHILIA A: AN INTRIGUING DISEASE: ACQUIRED HAEMOPHILIA A

Severe immune thrombocytopenia (ITP) following SARS-CoV-2 mRNA vaccine in a girl on immunosuppressive treatment and in prolonged stable phase of ITP: immune thrombocytopenia following mRNA vaccine

Single centre experience on Acquired Haemophilia A patients: Diagnosis, clinical management and analysis of factors predictive of response and outcome

Suchergebnisse filtern